Antares Pharma Announces Data Presentation at the 2018 Sexual Medicine Society Scientific Annual Meeting
XYOSTED™ AMBULATORY BLOOD PRESURE ABSTRACT HAS BEEN SELECTED FOR POSTER PRESENTATION EWING, N.J., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced that data from the 26-week Phase 3 study of the safety and tolerability …